Antigen presentation by pDCs could contribute to the induction of specific CD4+ and CD8+ T-cell responses [27, 28], but this would be contrary to the findings discussed above implying that high levels of pDCs in the tumor and low levels in the blood have a negative prognostic impact. This evidence concerns the gene CD4 and neoplasm.